Does adjuvant treatment improve prognosis after curative resection of ampulla of Vater carcinoma? A multicenter retrospective study
- 11 July 2020
- journal article
- research article
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 27 (10) , 721-730
Abstract
Introduction Ampulla of Vater (AoV) carcinoma is a rare tumor that accounts for approximately 0.2% of gastrointestinal malignancies. There are no clinical guidelines concerning the treatment of AoV carcinoma. This study aimed to investigate the effectiveness of adjuvant treatment in AoV carcinoma following curative resection and define the “high‐risk” group. Methods Clinical data of patients who underwent curative resection for AoV carcinoma in four hospitals, namely Yonsei Gangnam Severance Hospital, Seoul National University Hospital, Seoul National University Bundang Hospital, and National Cancer Center (n=651; 2002‐2015), were reviewed. Overall survival (OS) and recurrence‐free survival (RFS) rates were compared using Kaplan–Meier estimates. Results Data of 651 patients who had undergone curative resection were retrospectively reviewed. Age, T stage, N stage, and differentiation type remained strong and independent risk factors for RFS and OS. In early‐stage AoV carcinoma (T1N0, T2N0), the non‐adjuvant group had better prognosis based on the RFS and OS than the adjuvant group (p0.05). In node‐positive patients (any T, N1/2), adjuvant treatment did not affect RFS and OS (p>0.05). Conclusions Adjuvant treatment after curative resection of AoV carcinoma is not associated with improved survival. The high‐risk group (node‐positive or advanced T stage (T3, T4)) treated with adjuvant treatment was not statistically associated with improved survival; however, our study showed that the adjuvant treatment for the high‐risk group might help achieve better patient outcome.Keywords
This publication has 27 references indexed in Scilit:
- Ampullary carcinoma—A genetic perspectiveMutation Research - Reviews in Mutation Research, 2018
- Where does chemotherapy stands in the treatment of ampullary carcinoma? A review of literatureWorld Journal of Gastrointestinal Oncology, 2016
- Tumors of ampulla of Vater: A case series and review of chemotherapy optionsWorld Journal of Gastrointestinal Oncology, 2012
- Role of Adjuvant Chemoradiotherapy for Ampulla of Vater CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Role of Adjuvant Chemoradiation Therapy in Adenocarcinomas of the Ampulla of VaterInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Guidelines for chemotherapy of biliary tract and ampullary carcinomasJournal of Hepato-Biliary-Pancreatic Surgery, 2008
- Factors influencing recurrence after curative resection for ampulla of vater carcinomaJournal of Surgical Oncology, 2007
- Adjuvant therapy for ampullary carcinomas: The Mayo Clinic experienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Adjuvant chemo-radiotherapy in ampullary cancersEuropean Journal of Surgical Oncology, 2005
- Adjuvant Chemoradiotherapy for "Unfavorable" Carcinoma of the Ampulla of VaterArchives of Surgery, 2001